Cyera vs Andson Biotech

Side-by-side comparison of AI visibility scores, market position, and capabilities

Cyera leads in AI visibility (69 vs 41)
Cyera logo

Cyera

LeaderTechnology

General

NYC AI-powered DSPM + DLP unicorn; $460M+ total ($300M Series C Jan 2024 at $1.4B) with Trail Security $162M acquisition Oct 2024 creating Unified Data Security Platform competing with Varonis for cloud data protection.

AI VisibilityBeta
Overall Score
B69
Category Rank
#76 of 1158
AI Consensus
49%
Trend
down
Per Platform
ChatGPT
66
Perplexity
60
Gemini
76

About

Cyera is a New York City-based AI-powered data security platform — backed with $460+ million in total funding including a $300 million Series C in January 2024 at a $1.4 billion valuation (unicorn) from Accel, Sequoia Capital, and Redpoint Ventures — providing enterprise security teams with Data Security Posture Management (DSPM) and integrated Data Loss Prevention (DLP) for discovering, classifying, and protecting sensitive data across cloud environments, SaaS applications, and on-premises infrastructure. In October 2024, Cyera acquired Trail Security for $162 million — adding DLP capabilities to create the market's first Unified Data Security Platform combining data-at-rest protection (DSPM) with data-in-motion enforcement (DLP). The platform uses a proprietary GenAI LLM for autonomous data classification at 95%+ accuracy with an agentless architecture requiring no endpoint software installation. Founded in 2021 by Yotam Segev (CEO) and Tamar Bar-Ilan (CTO); the company self-described as the fastest-growing data security company in history.

Full profile
Andson Biotech logo

Andson Biotech

EmergingHealthcare

General

Mass spectrometry sample prep and data science platform delivering 100x productivity for biopharma protein analysis; $9.1M from Merck Digital Sciences Studio, NIH, and YC at $1.8M revenue.

AI VisibilityBeta
Overall Score
C41
Category Rank
#220 of 1158
AI Consensus
62%
Trend
up
Per Platform
ChatGPT
49
Perplexity
36
Gemini
40

About

Andson Biotech is an Atlanta-based healthcare technology company providing mass spectrometry solutions for biopharma and biomanufacturing — offering the DynaCHIP hardware system (a novel mass spectrometry sample preparation platform) and DynaMARK data science module that together deliver up to 100x productivity improvements in protein and biomolecule analysis workflows compared to conventional mass spectrometry setups. Backed by Y Combinator, Merck Digital Sciences Studio, and NIH with $9.1 million raised, Andson achieved $1.8 million in revenue as of December 2024.

Full profile

AI Visibility Head-to-Head

69
Overall Score
41
#76
Category Rank
#220
49
AI Consensus
62
down
Trend
up
66
ChatGPT
49
60
Perplexity
36
76
Gemini
40
80
Claude
41
77
Grok
51

Key Details

Category
General
General
Tier
Leader
Emerging
Entity Type
brand
brand

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.